Option Care Health, Inc. $OPCH Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. reduced its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 5.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 16,647,553 shares of the company’s stock after selling 1,039,159 shares during the quarter. Vanguard Group Inc. owned 0.10% of Option Care Health worth $530,391,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the business. Directional Asset Management purchased a new position in Option Care Health in the fourth quarter valued at $10,018,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Option Care Health by 3.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 53,188 shares of the company’s stock valued at $1,695,000 after acquiring an additional 1,600 shares in the last quarter. Merit Financial Group LLC purchased a new stake in Option Care Health during the 4th quarter valued at about $1,280,000. Phocas Financial Corp. purchased a new stake in Option Care Health during the 4th quarter valued at about $4,163,000. Finally, Retirement Guys Formula LLC purchased a new stake in Option Care Health during the 4th quarter valued at about $218,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Activity

In related news, CEO John Charles Rademacher purchased 12,500 shares of Option Care Health stock in a transaction dated Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the purchase, the chief executive officer owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on OPCH. Citizens Jmp reaffirmed a “market outperform” rating and set a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research note on Tuesday, January 13th. UBS Group decreased their target price on shares of Option Care Health from $45.00 to $39.00 and set a “buy” rating on the stock in a report on Friday. Truist Financial set a $30.00 target price on shares of Option Care Health in a report on Friday. JPMorgan Chase & Co. decreased their target price on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a report on Monday. Finally, National Bank Financial set a $37.00 target price on shares of Option Care Health in a report on Tuesday, January 27th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $32.08.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $21.14 on Tuesday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The firm has a market capitalization of $3.32 billion, a price-to-earnings ratio of 16.39, a PEG ratio of 1.12 and a beta of 0.68. The company’s 50-day moving average is $29.15 and its two-hundred day moving average is $30.74. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. Option Care Health’s revenue was up 1.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Analysts forecast that Option Care Health, Inc. will post 1.69 EPS for the current year.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.